John P Renton, MD | |
2450 Ne Mary Rose Pl Ste 120, Bend, OR 97701-7132 | |
(541) 312-6784 | |
(541) 312-7057 |
Full Name | John P Renton |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 2450 Ne Mary Rose Pl Ste 120, Bend, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1780893008 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 151280 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
John P Renton, MD 2450 Ne Mary Rose Pl Ste 120, Bend, OR 97701-7132 Ph: (541) 312-6784 | John P Renton, MD 2450 Ne Mary Rose Pl Ste 120, Bend, OR 97701-7132 Ph: (541) 312-6784 |
News Archive
Powder processing lies at the heart of pharmaceutical manufacture. It is therefore necessary that efforts to improve efficiency and preserve quality must focus on understanding and controlling powder behaviour.
AstraZeneca today announced preliminary efficacy and safety data for AZD9291 in the first-line treatment of epidermal growth factor receptor mutation positive (EGFRm) advanced non-small cell lung cancer (NSCLC).
Bioengineers at the University of California, San Diego have discovered that mouse embryos are contemplating their cellular fates in the earliest stages after fertilization when the embryo has only two to four cells, a discovery that could upend the scientific consensus about when embryonic cells begin differentiating into cell types.
Onyx Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) determined by a vote of 11-0 with 1 abstention that, in patients with relapsed and refractory multiple myeloma who have received at least two prior lines of therapy that included a proteasome inhibitor and an immunomodulatory agent (IMiD), the benefit-risk assessment is favorable for the use of Kyprolis.
According to a new book, Getting Control of Your Anger: A Clinically Proven, Three-Step Plan for Getting to the Root of the Problem and Resolving It (McGraw-Hill, 2006) by Dr. Robert Allan, a noted clinical psychologist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, for most people and in most circumstances, directly expressed anger will only make a bad situation worse.
› Verified 5 days ago
Michael E Villano, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 431 Ne Revere Ave, Suite B, Bend, OR 97701 Phone: 541-312-1145 | |
Dr. Ryan P Gallivan, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2450 Ne Mary Rose Pl, Suite 120, Bend, OR 97701 Phone: 541-382-3100 Fax: 541-312-7050 | |
Matthew L Hinsley, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2450 Ne Mary Rose Pl Ste 120, Bend, OR 97701 Phone: 505-661-4147 | |
Kenneth Arthur Bagwell, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2450 Ne Mary Rose Pl Ste 120, Bend, OR 97701 Phone: 203-688-2259 Fax: 203-688-5599 | |
J David Wood, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2450 Ne Mary Rose Pl, Suite 120, Bend, OR 97701 Phone: 541-312-6799 Fax: 541-312-7050 | |
Dr. C Christian Friess, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2450 Ne Mary Rose Pl, Ste 120, Bend, OR 97701 Phone: 541-382-3100 Fax: 541-312-7050 | |
Dr. William C Laws, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2450 Ne Mary Rose Pl, Suite 120, Bend, OR 97701 Phone: 541-382-3100 Fax: 541-312-7050 |